AddLife AB (publ)
ALIF-B.ST
Get informed when a big investor buys or sells
+ FollowMarket Cap$20.66B
Close$
$78.45
57.6% downside
Current Fair Value
57.6% downsideOvervalued by 57.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $20.66 Billion |
|---|---|
| Enterprise Value | $25.28 Billion |
| Dividend Yield | $1.50 (0.89%) |
| Earnings per Share | $4.6 |
| Beta | 1.55 |
| Outstanding Shares | 121,864,000 |
Return
| Return on Equity | 10.51% |
|---|---|
| Return on Assets | 4.53% |
| Return on Invested Capital | 8.97% |
Valuation & Multiples
| P/E Ratio | 34.63 |
|---|---|
| PEG | 115.44 |
| Price to Sales | 2.15 |
| Price to Book Ratio | 4.03 |
| Enterprise Value to Revenue | 2.4 |
| Enterprise Value to EBIT | 31.02 |
| Enterprise Value to Net Income | 42 |
| Total Debt to Enterprise | 0.2 |
| Debt to Equity | 0.88 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 16, 2026
EPS Estimate
$1.04
Average shareholder expectationRevenue Estimate
$2.67 B
Average shareholder expectationNext Earnings Call
Expected Date
October 21, 2026
EPS Estimate
$0.86
Average shareholder expectationRevenue Estimate
$2.58 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About AddLife AB Class B
2,295 employees
CEO: Fredrik Dalborg AddLife AB (publ), together with its subsidiaries, provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries. The comp...